Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antianaphylaxis(antihistamines) and antidotes > Vinorelbine tartrate
Vinorelbine tartrate
Inquiry
| Post Date: | Apr 28,2014 |
| Expiry Date: | Apr 28,2015 |
| Detailed Description: |
Cas No. :125317-39-7
Payment Method: T/T advance Product Name ：Vinorelbine tartrate Synonyms ：3',4'-Didehydro-4'-deoxy-C'-norvincaleukoblastine Molecular formula ：C45H54N4O8·2C4H6O6 Molecular weight ：1079.11 CAS NO. ：125317-39-7 Appearance ：White or almost white crystalline powder Purity(HPLC) ：≥99.0% Quality standard ：USP36 EP7.0 CEP No: R0-CEP 2009-394-Rev 01 Packing ：10g/bag,20g/bag Storage conditions ：Protect from light, tightly sealed, freezer storage(less than -20℃). Descriptions ：It is an anti-cancer drug, semi-synthesis from derivative of vincamedine, which is for the equilibrium of microtubule protein or capillary's dynamical, suppressing polymerization of microtubule protein through G2 and the M. It is used for the treatment of the non-cellule lung cancer, transferring breast cancer, lymphoma, ovarian cancer, etc. |
| CAS Registry Number: | 125317-39-7 |
| Synonyms: | ;Vinorelbine bitartrate;3',4'-didehydro-4'-deoxy-c'-norvincaleukoblastine R-(R*,R*)-2-3-dihydroxybutanedioate (1:2) salt;Navelbine tartrate;Nvb;Navelbine;Vinorelbin;Bitartrate;Vinorelbine ditartaric acid;Vinorelbine ditartrate salt;Butanedioate(1:2);C'-norvincaleukoblastine,3',4'-didehydro-4'-dioxy-,(R-(R*,R*))-2,3-dihydroxy;5'-noranhydrovinoblastine tartrate;3',4'-didehydro-4'-deoxy-c'-norvincaleukoblastine;[R-(R*,R*)-2-3-dihydroxybutanedioate (1:2) salt];Pacilitaxel;Vinorelbineditartrate salt hydrate;Vinorelbine tartrate usp standard;Vinorelbine tartrate;Vinorelbine bitratrate;Vinorelbine tartarate;methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate 2,3-dihydroxybutanedioate (1:2);methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate 2,3-dihydroxybutanedioate (1:2);methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate;(3Ar,3A1R,4R,5S,5Ar,10Br)-Methyl 4-Acetoxy-3A-Ethyl-9-((2S,6S,8S)-4-Ethyl-8-(Methoxycarbonyl)-1,3,6,7,8,9-Hexahydro-2,6-Methanoazecino[4,3-B]Indol-8-Yl)-5-Hydroxy-8-Methoxy-6-Methyl-3A,3A1,4,5,5A,6,11; |
| Molecular Formula: | C45H54N4O8 |
| Molecular Weight: | 778.9323 |
| Molecular Structure: | 
|
| Hazard Symbols: |  Xi:Irritant; |
| Risk Codes: | R43:; |
| Safety Description: | S26:; S36:; |
| Company: | Hubei Honch Pharmaceutical Co.,Ltd [ China ] |
| Contact: | Emily |
| Tel: | +86-713-7229222 |
| Fax: | +86-713-7223777 |
| Email: | vet@hcpharm.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
